Ferrlecit (sanofi-aventis U.S. LLC)


Welcome to the PulseAid listing for the Ferrlecit drug offered from sanofi-aventis U.S. LLC. This Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: sanofi-aventis U.S. LLC
NON-PROPRIETARY NAME: sodium ferric gluconate complex
SUBSTANCE NAME: SODIUM FERRIC GLUCONATE COMPLEX
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2011-03-01
END MARKETING DATE: 0000-00-00


Ferrlecit HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFerrlecit from sanofi-aventis U.S. LLC
LABELER NAME: sanofi-aventis U.S. LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 12.5(mg/mL)
START MARKETING DATE: 2011-03-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0024-2792_d4a8b488-b33f-456d-bb00-4932fe4cebda
PRODUCT NDC: 0024-2792
APPLICATION NUMBER: NDA020955

Other SODIUM FERRIC GLUCONATE COMPLEX Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Sodium Ferric Gluconate Complex
sanofi-aventis U.S. LLCFerrlecit
West-Ward Pharmaceutical CorpSodium Ferric Gluconate Complex in Sucrose
West-Ward Pharmaceuticals CorpSodium Ferric Gluconate Complex in Sucrose